Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Etoposide × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 198 Lymphoma, Large B-Cell, Diffuse 143 Precursor Cell Lymphoblastic Leukemia-Lymphoma 129 Lymphoma, Non-Hodgkin 122 Hodgkin Disease 98 Burkitt Lymphoma 89 Leukemia 78 Lymphoma, Follicular 75 Lymphoma, Mantle-Cell 64 Lymphoma, Large-Cell, Immunoblastic 63 Leukemia, Lymphocytic, Chronic, B-Cell 54 Lymphoma, B-Cell, Marginal Zone 40 Leukemia, Myeloid, Acute 32 Dendritic Cell Sarcoma, Interdigitating 27 Recurrence 26 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, Large-Cell, Anaplastic 24 Lymphoma, B-Cell 24 Myelodysplastic Syndromes 22 Multiple Myeloma 22 Lymphoma, Extranodal NK-T-Cell 20 Waldenstrom Macroglobulinemia 19 Blast Crisis 19 Leukemia, Myeloid, Accelerated Phase 18 Lymphoma, T-Cell, Peripheral 17 Congenital Abnormalities 17 Myeloproliferative Disorders 16 Lymphoma, T-Cell, Cutaneous 16 Leukemia, Myeloid, Chronic-Phase 16 Neoplasms, Plasma Cell 15

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡